The Use of Stilbene Scaffold in Medicinal Chemistry and Multi-Target Drug Design

被引:72
|
作者
Giacomini, Elisa [1 ]
Rupiani, Sebastiano [2 ]
Guidotti, Laura [2 ]
Recanatini, Maurizio [2 ]
Roberti, Marinella [2 ]
机构
[1] Ist Italiano Tecnol, CompuNet, Via Morego 30, I-16163 Genoa, Italy
[2] Univ Bologna, Dept Pharm & Biotechnol, Via Belmeloro 6, I-40126 Bologna, Italy
关键词
Alkene arylation; Alzheimer's disease; Cancer; Combretastatin; Diethylstilbestrol; Double bond formation; Hybrid compounds; Resveratrol; HISTONE DEACETYLASE INHIBITORS; ESTROGEN-RECEPTOR MODULATORS; DIRECTED RESVERATROL DERIVATIVES; COMBRETASTATIN A-4 PHOSPHATE; A-BETA AGGREGATION; ANTINEOPLASTIC AGENTS; BIOLOGICAL EVALUATION; ALZHEIMERS-DISEASE; TRANS-RESVERATROL; ROOM-TEMPERATURE;
D O I
10.2174/0929867323666160517121629
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The stilbene scaffold is a basic element for a number of biologically active natural and synthetic compounds, and it is considered as a privileged structure. Stilbenes exemplified by resveratrol, combretastatin A-4 and pterostilbene are of significant interest for drug research and development because of their potential in therapeutic and preventive application. Resveratrol, present in grapes and other food products, plays a role in the prevention of several human pathological processes and has been suggested as an anticancer agent. Moreover, recent evidence has revealed its potential effect on the aging process, diabetes and neurological dysfunction. Combretastatin A-4, from the bark of South African bush willow Combretum caffrum, also shows significant antitumor activity. Pterostilbene is closely related to resveratrol, sharing the same unique therapeutic potential as anti-inflammatory, antineoplastic and antioxidant agent. Therefore, research and development of stilbene-based medicinal chemistry have become rapidly evolving and increasingly active topics covering almost the whole range of therapeutic fields. In the present review, we provide an overview of the role of stilbenes in medicinal chemistry. In this context, we highlight the chemical methodologies adopted for the synthesis of stilbene derivatives, and outline the successful design of novel stilbene based hybrids in the field of cancer, Alzheimer's and other relevant diseases. This information may be useful in further design of stilbene-based molecules as new leads for the development of novel agents with clinical potential or as effective chemical probes to dissect biological processes.
引用
收藏
页码:2439 / 2489
页数:51
相关论文
共 50 条
  • [1] The Latest Researches of Enzyme Inhibition and Multi-Target Drug Predictors in Medicinal Chemistry
    Zhou, Guo-Ping
    MEDICINAL CHEMISTRY, 2019, 15 (06) : 572 - 573
  • [2] Multi-Target Drug Discovery in Medicinal Chemistry: Current Status and Future Perspectives
    Speck-Planche, Alejandro
    Cordeiro, M. Natalia D. S.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2015, 15 (08) : 606 - 607
  • [3] In-Silico Approaches to Multi-target Drug DiscoveryComputer Aided Multi-target Drug Design, Multi-target Virtual Screening
    Xiao Hua Ma
    Zhe Shi
    Chunyan Tan
    Yuyang Jiang
    Mei Lin Go
    Boon Chuan Low
    Yu Zong Chen
    Pharmaceutical Research, 2010, 27 (5) : 739 - 749
  • [4] Explainable machine learning for medicinal chemistry: exploring multi-target compounds
    Bajorath, Juergen
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (16) : 1171 - 1173
  • [5] The benefits of the multi-target approach in drug design and discovery
    Espinoza-Fonseca, LM
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (04) : 896 - 897
  • [6] Drug target residence time in design: A medicinal chemistry perspective
    Millan, David S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [7] Discovering multi-target and single-target agents for major psychiatric diseases: The medicinal chemistry challenges
    Morphy, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 52 - 52
  • [8] A perspective on multi-target drug discovery and design for complex diseases
    Ramsay, Rona R.
    Popovic-Nikolic, Marija R.
    Nikolic, Katarina
    Uliassi, Elisa
    Bolognesi, Maria Laura
    CLINICAL AND TRANSLATIONAL MEDICINE, 2018, 7
  • [9] Multi-Target in Computer-Aided Drug Design Studies
    Scotti, Luciana
    Scotti, Marcus T.
    CURRENT DRUG TARGETS, 2017, 18 (05) : 498 - 499
  • [10] Recent Advances in the Rational Drug Design Based on Multi-target Ligands
    Yang, Ting
    Sui, Xin
    Yu, Bing
    Shen, Youqing
    Cong, Hailin
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (28) : 4720 - 4740